project id: TCGA-BLCA; case submitter id: TCGA-XF-AAN2; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.13; rna integrity number: 9.2; age at index: 73; days to birth: -26720; days to death: 1869; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1934; year of death: 2012; age at diagnosis: 26720; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; composition: Not Reported; days to collection: 2505; days to sample procurement: 0; initial weight: 280.0; portion submitter id: TCGA-XF-AAN2-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 20.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 65.0; percent tumor nuclei: 65.0;